Your search returned 11 results.

Results
	1.	[Skull and tooth abnormalities in a patient with osteopathia striata]. [electronic resource] by De Boer, S M Van Gool, A V Producer: 19741216 In: Nederlands tijdschrift voor geneeskunde vol. 118 Availability: No items available. Save to lists Add to cart (remove)
	2.	A controlled trial of senna preparations and other laxatives used for bowel cleansing prior to radiological examination. [electronic resource] by Brouwers, J R van Ouwerkerk, W P de Boer, S M Thoman, L Producer: 19800712 In: Pharmacology vol. 20 Suppl 1 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Acid-activated structural reorganization of the Rift Valley fever virus Gc fusion protein. [electronic resource] by de Boer, S M Kortekaas, J Spel, L Rottier, P J M Moormann, R J M Bosch, B J Producer: 20130128 In: Journal of virology vol. 86 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Rift Valley fever virus immunity provided by a paramyxovirus vaccine vector. [electronic resource] by Kortekaas, J de Boer, S M Kant, J Vloet, R P M Antonis, A F G Moormann, R J M Producer: 20100901 In: Vaccine vol. 28 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Heparan sulfate facilitates Rift Valley fever virus entry into the cell. [electronic resource] by de Boer, S M Kortekaas, J de Haan, C A M Rottier, P J M Moormann, R J M Bosch, B J Producer: 20130128 In: Journal of virology vol. 86 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Rift Valley fever virus subunit vaccines confer complete protection against a lethal virus challenge. [electronic resource] by de Boer, S M Kortekaas, J Antonis, A F Kant, J van Oploo, J L Rottier, P J M Moormann, R J M Bosch, B J Producer: 20100511 In: Vaccine vol. 28 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	Efficacy of three candidate Rift Valley fever vaccines in sheep. [electronic resource] by Kortekaas, J Antonis, A F G Kant, J Vloet, R P M Vogel, A Oreshkova, N de Boer, S M Bosch, B J Moormann, R J M Producer: 20120808 In: Vaccine vol. 30 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	Intramuscular inoculation of calves with an experimental Newcastle disease virus-based vector vaccine elicits neutralizing antibodies against Rift Valley fever virus. [electronic resource] by Kortekaas, J Dekker, A de Boer, S M Weerdmeester, K Vloet, R P M de Wit, A A C Peeters, B P H Moormann, R J M Producer: 20100511 In: Vaccine vol. 28 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	9.	A glycerophospholipid-specific pocket in the RVFV class II fusion protein drives target membrane insertion. [electronic resource] by Guardado-Calvo, P Atkovska, K Jeffers, S A Grau, N Backovic, M Pérez-Vargas, J de Boer, S M Tortorici, M A Pehau-Arnaudet, G Lepault, J England, P Rottier, P J Bosch, B J Hub, J S Rey, F A Producer: 20180316 In: Science (New York, N.Y.) vol. 358 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	10.	Clinical consequences of upfront pathology review in the randomised PORTEC-3 trial for high-risk endometrial cancer. [electronic resource] by de Boer, S M Wortman, B G Bosse, T Powell, M E Singh, N Hollema, H Wilson, G Chowdhury, M N Mileshkin, L Pyman, J Katsaros, D Carinelli, S Fyles, A McLachlin, C M Haie-Meder, C Duvillard, P Nout, R A Verhoeven-Adema, K W Putter, H Creutzberg, C L Smit, V T H B M Producer: 20190401 In: Annals of oncology : official journal of the European Society for Medical Oncology vol. 29 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	11.	Ten-year results of the PORTEC-2 trial for high-intermediate risk endometrial carcinoma: improving patient selection for adjuvant therapy. [electronic resource] by Wortman, B G Creutzberg, C L Putter, H Jürgenliemk-Schulz, I M Jobsen, J J Lutgens, L C H W van der Steen-Banasik, E M Mens, J W M Slot, A Kroese, M C Stenfert van Triest, B Nijman, H W Stelloo, E Bosse, T de Boer, S M van Putten, W L J Smit, V T H B M Nout, R A Producer: 20190823 In: British journal of cancer vol. 119 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)